Breast Cancer Survivor’s Views on Duration of Follow Up

Jasim Amin, Michael McKirdy

Department of Surgery, Breast Surgery, Inverclyde Royal Hospital, Greater Glasgow and Clyde Health Board, Glasgow, UK.

DOI: 10.4236/abcr.2013.22004                

Abstract

Background: Breast cancer is one of the commonest cancers in women in the UK and western countries [1]. Follow ups after breast cancer diagnosis is usual practice, but there is no agreed consensus among breast care providers on frequency or duration of follow up after diagnosis and adjuvant treatment. The aim of this study is to find out women’s views on the period of the clinical follow up after breast cancer diagnosis. Method: This was a surveillance study in Greenock and Glasgow in the UK (Between September 2009 and December 2010). The study group comprised of 446 Women, 246 with the history of breast cancer diagnosed 1 - 10 years, (median 4.2 years) were asked to complete a questionnaire about their views of preferred duration of follow up while they were waiting for the annual review at a breast clinic, the same questionnaire was completed by 200 women with no history of breast cancer. Results: Between September 2009 and December 2010, 246 patients were included in the study. 40% of patients were within the first three years of follow up, 27% between the 4th and 6th year and 33% were in follow-up for more than 6 years. 63% of cancer survivors think that, 10 years of follow up is necessary for reassurance, detection and treatment of any new, recurrent or spread of their breast cancer. 14% and 22% of women with a history of breast cancer preferred 3 and 5 years review by trained Radiologist/GP respectively. Women without a history of breast cancer were different in their thoughts about follow up after breast cancer: 10%, 25%, and 30% chosen 10, 5 and 3 years, 35% preferred don’t know the answer. Conclusion: Follow up programs for breast cancer survivors need to be organized, evidence based, flexible and patient tailored. Patients’ views should be taken into account when considering provision of follow-up care for breast cancer patients.

Keywords

Breast Cancer; Follow Up; Survivors; View; Clinic

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers and D. M. Parkin, “Women and Cancer: Screening and Treatment Save Lives Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, Vol. 127, No. 12, 2010, pp. 2893-2917. doi:10.1002/ijc.25516
[2]	D. M. Parkin, S. L. Whelan, J. Ferlay, L. Teppoand and D. B. Thomas, “Cancer Incidence in Five Continents,” Vol. 8, IARC Scientific Publications No. 155, Lyons, 2003. Office for National Statistics, Series MB1 No. 39, National Statistics, London, 2010.
[3]	Cancer Research UK, “Living Well beyond Breast Cancer: A Survivor’s Guide for When Treatment Ends and the Rest of Your Life Begins,” 2nd Edition, Three Rivers Press, Marisa and Ellen Weiss, 2010.
[4]	R. L. Bowen, et al., “Early Onset of Breast Cancer in a Group of British Black Women,” British Journal of Cancer, Vol. 98, No. 2, 2008, pp. 277-281. doi:10.1038/sj.bjc.6604174
[5]	J. Maddams, H. Moller and C. Devane, “Cancer Prevalence in the UK, 2008. Thames Cancer Registry and Macmillan Cancer Support,” 2008. http://www.thames-cancer-reg.org.uk/news/uk_ prevalence_14072008.pdf
[6]	S. Potter, S. Govindarajulu, M. Shere, F. Braddon, J. Turner, A. K. Sahu and S. J. Cawthorn, “Does Limiting Long-Term Follow-Up for Breast Cancer Allow All Referrals to Be Seen in 2 Weeks?” Annals of The Royal College of Surgeons of England, Vol. 90, No. 5, 2008, pp. 381-385. doi:10.1308/003588408X301181
[7]	J. Jassem, M. Buchanan, F. JAnicke, M. Baum, L. Cataliotti, S. L. Kyriakides, M. Piccart, E. J. T. Rutgers and A. Costa, “The Hamburg Statement: The Partnership Driving the European Agenda on Breast Cancer,” European Journal of Cancer, Vol. 40, No. 12, 2004, pp. 1810-1811. doi:10.1016/j.e jca.2004.04.020
[8]	D. A. Montgomery, K. Krupa and T. G. Cooke, “Follow-Up in Breast Cancer: Does Routine Clinical Examination Improve Outcome? A Systematic Review of the Literature,” University Department of Surgery, Queen Elizabeth Building, Glasgow Royal Infirmary, Glasgow, 2007.
[9]	M. Brennan, P. Butow, A. J. Spillane, M. Marven and F. M. Boyle, “Follow up after Breast Cancer—Views of Australian Women,” Australian Family Physician, Vol. 40, No. 5, 2011, pp. 311-316.
[10]	S. Lawler, K. Spathonis, J. Masters and J. Adams, “Follow-Up Care after Breast Cancer Treatment: Experiences and Perceptions of Service Provision and Provider Interactions in Rural Australian Women,” Supportive Care in Cancer, Vol. 19, No. 12, 2011, pp. 1975-1982. doi:10.1007/s00520-010-1041-4
[11]	M. Al-Gailani, P. Dudani, M. Fletcher, S. Beard and A Parkin, “Breast Cancer Follow-Up: What about the Patients’ Views?” European Journal of Surgical Oncology, Vol. 36, No. 11, 2010, p. 1119. doi:10.1016/j.ejso.2010.08.050
[12]	K. Beaver, S. Williamson and K. Chalmers, “Telephone Follow-Up after Treatment for Breast Cancer: Views and Experiences of Patients and Specialist Breast Care Nurses,” Journal of Clinical Nursing, Vol. 19, No. 19-20, 2010, pp. 2916-2924. doi:10.1111/j.1365-2702.2010.03197.x
[13]	E. Greimel, “Patients’ View of Routine Follow-Up after Breast Cancer Treatment,” 2011 ASCO Annual Meeting, 3-7 June 2011, Category: Patient and Survivor Care— Quality of Life Mgmt, Chicago, Article ID: e19516.
[14]	F. M. Kew and K. Galaal, “Patients’ Views of Follow-Up after Treatment for Gynaecological Cancer,” Journal of Obstetrics & Gynaecology, Vol. 29, No. 2, 2009, pp. 135-142. doi:10.1080/01 443610802646801
[15]	S. Morris, “What Are the Benefits of Routine Breast Cancer Follow-Up?” Postgraduate Medical Journal, Vol. 68, No. 805, 1992, pp. 904-907. doi:10.1136/pgmj.68.805.904
[16]	K. Beaver, D. Tysver-Robinson and M. Campbell, “Comparing Hospital and Telephone Follow-Up after Treatment for Breast Cancer: Randomised Equivalence Trial,” British Medical Journal, Vol. 338, 2009, p. 337. doi:10.1136/bmj.a3147
[17]	S. Carmel, “Breast Cancer Follow-Up: Literature Review and Discussion,” European Journal of Oncology Nursing, Vol. 11, No. 4, 2007, pp. 340-347.
[18]	E. Grunfeld, “Primary Care Physicians and Oncologists Are Players on the Same Team,” American Society of Clinical Oncology, Vol. 26, No. 14, 2008, pp. 2246-2247.
[19]	P. Donnelly, L. Hiller, S. Bathers and S. Bowden, “Questioning Specialists’ Attitudes to Breast Cancer Follow-Up in Primary Care,” Annals of Oncology, Vol. 18, No. 9, 2007, pp. 1467-1476.
[20]	M. E. Del Giudice, E. Grunfeld and B. J. Harvey, “Primary Care Physicians’ Views of Routine Follow-Up Care of Cancer Survivors,” Journal of Clinical Oncology, Vol. 27, No. 20, 2009, pp. 3338-3345.
[21]	M. Vanhuyse, P. Bedard, J. Sheiner, B. Fitzgerald and M. Clemons, “Transfer of Follow-Up Care to Family Physicians for Early-Stagebreast Cancer,” Clinical Oncology, Vol. 19, No. 3, 2007, pp. 172-176. doi:10.1016/j.clon.2007.01.115